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Abstract Articular cartilage is a unique load-bearing connec-
tive tissue with a low intrinsic capacity for repair and regen-
eration. Its avascularity makes it relatively hypoxic and its
unique extracellular matrix is enriched with cations, which
increases the interstitial fluid osmolarity. Several physico-
chemical and biomechanical stimuli are reported to influence
chondrocyte metabolism and may be utilized for regenerative
medical approaches. In this review article, we summarize the
most relevant stimuli and describe how ion channels may
contribute to cartilage homeostasis, with special emphasis on
intracellular signaling pathways. We specifically focus on the
role of calcium signaling as an essential mechanotransduction
component and highlight the role of phosphatase signaling in
this context.
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Introduction
The unique biomechanical properties of articular cartilage are
attributed to the structure, composition, and organization of its
extracellular matrix (ECM) macromolecules. The cartilage
ECM is mainly composed of a collagen fiber network (type
II collagen with type IX and XI) and large aggregating pro-
teoglycans (PGs) entrapped within. The fixed negative
charges on the glycosaminoglycan (GAG) side chains of
PGs attract counteracting ions, which drive the movement of
large amounts of osmotically obliged water into the matrix [1].
The high osmotic milieu and the tissue swelling maintain the
hydrostatic pressure and viscoelastic properties of cartilage.
The highly sulfated GAG side chains of PGs, through
attracting mobile cations, are responsible for the characteristi-
cally high negative fixed-charge density (FCD) [2].
Intertwined collagens and PGs combine to create the tissue
rigidity by entrapping solutes and water, giving cartilage its
unique biomechanical properties, to withstand large compres-
sive and shear forces without failing [3]. Articular cartilage
absorbs stresses generated during joint loading and contrib-
utes to joint lubrication [1, 4]. An intact collagen network
restricts swelling and, in combination with sulfated GAGs,
determines the osmotic pressure (OP) of the extracellular fluid
around chondrocytes, which ranges from 350 to 480 mOsm in
healthy cartilage [5].
The electrochemical properties of articular cartilage arise
from the flow of “free” electrolytes (e.g., Na+, K+, Ca2+) pass-
ing the relatively “fixed” FCD (e.g., SO4
2−) distributed along
the PGs [6] resulting in electrokinetic phenomena and charge-
dependent osmotic swelling pressures (i.e., Donnan osmotic
pressure) [7–9]. The FCD permits tissue hydration, charged
species transport, and other electrochemical responses [10].
Mow et al. postulated that the ECM is a mechanical signal
transducer, receiving loading as input to generate an output of
multiple biophysical signals [11].
Interestingly, reports on physiologically relevant values of
tensile or shear forces in natural cartilage or in tissue-
engineered constructs are sparse [12], as is the knowledge
about the molecular identity of the sensory components and
signaling apparatus that convert various environmental forces
(e.g., deformation, shear stress and fluid flow, hydrostatic
pressure (HP), and extracellular ionic milieu (i.e., OP) as well
as magnetic and electric forces), into cellular responses. We
provide a brief overview of how these forces might be
exploited to facilitate cartilage regeneration, with special em-
phasis on intracellular signaling, which is often understudied
in the context of cartilage bioengineering.
Cartilage Pathologies
Traumatic local damage [13–15], usually in younger patients,
and whole joint erosion, as in osteoarthritis (OA) [16] in the
elderly, are challenging areas of regenerative orthopedics [17].
To date, there is no successful targeted therapy that would halt
or even reverse OA progression; current management includ-
ing inflammatory medications, total joint replacements, or an-
algesics only allow palliative treatment [18•]. There is a press-
ing need for targeted treatment options, ideally at the early,
asymptomatic stages of the disease. The earliest signs of ar-
ticular cartilage degeneration during OA are net depletion of
PGs [10, 19–21], subsequent loss of the collagen network
[22], and diminished intrinsic compressive stiffness, affecting
chondrocyte deformation, metabolic activities, and electrome-
chanical events within cartilage under body load [10, 23].
Severity-dependent catabolic events during the course of OA
reduce extracellular osmolarity, resulting in reduced viscoelas-
tic tissue properties, corresponding biomechanical inferiority
[5, 24], and eventually increased deformation of cartilage un-
der mechanical load. Elevated levels of inflammatory media-
tors that promote matrix degradation may also accompany
these changes.
Regenerative Approaches
Autologous chondrocyte implantation (ACI) [25] surpasses
existing procedures for treating focal defects, but is unable
to fully restore functional hyaline cartilage ad integrum. A
potentially better procedure for structurally repairing symp-
tomatic cartilage defects in the knee is characterized chondro-
cyte implantation (CCI) which has a more favorable outcome
compared to microfracturing [26].
A major challenge is the complex zonal structure of carti-
lage tissue, which is important for its load-bearing properties
[27–29]. The sparse available data indicate that mechanical
properties significantly vary between articular cartilage zones
[30–32]. The lack of mechanical homogeneity may be impor-
tant for mechanosensation, signal transduction, and chondro-
cyte phenotypic stability.
Another major challenge of present tissue engineering
strategies for cartilage repair is the limited integration of the
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constructs into the surrounding host tissue [33], often resulting
in local cell death at the defect margins [34]. The goal, there-
fore, is to create tissue functionality prior to implantation by
enhancing the rate and quality of tissue growth through creat-
ing in vivo-like conditions in vitro. Various environmental
stimuli for promoting cartilage regeneration are discussed in
the following sections.
Stimulating Functional Cartilage Tissue Engineering
Electrical Stimulation
Mechanoelectrical transduction phenomena occurring natural-
ly within the cartilage due to the FCD have prompted the
development of experimental electrical stimulation protocols
for therapeutic cartilage repair [35, 36]. Therapeutic devices
involving electrical stimulation are increasingly entering the
clinical market [37], despite rather discouraging early results
[38, 39]. More recently, Brighton et al. observed anabolic
effects [40] that may hold potential to treat osteoarthritic le-
sions [18•]. Our current appreciation of underlying molecular
mechanisms, however, is rudimentary.
Magnetic Stimulation
Since its FDA approval in 1979, pulsed electromagnetic field
(PEMF) therapy has been widely used in orthopedics to treat
poorly healing fractures [41, 42•]. Although the biology of
how PEMF stimulates bone formation is only partially under-
stood [43] and may originate from stimulating progenitor cell
differentiation [44], its clinical use has provided a rationale for
applying (P)EMF in musculoskeletal tissue engineering [45,
46].
Data from randomized controlled trials now suggest that
PEMF improves clinical scores and function even in pa-
tients with knee OA [47]. While (low-frequency) PEMF
therapy barely influences the biosynthetic activity of hu-
man OA chondrocytes in vitro [48], it increases PG release
in alginate culture [49]. PEMF increases anti-inflammatory
effects in the human costal chondrocyte cell line T/C-28a2
[50], and, like IGF-1, it augments chondroprotective anabolic
activities such as PG synthesis in human OA cartilage explants,
possibly by counteracting the effects of IL-1β in early stages of
OA [51]. A study in ovariectomized rats, aiming at simu-
lating postmenopausal osteoarthritis, reported an interest-
ing systemic effect of PEMF therapy on estrogen metab-
olism that reduced apoptosis and matrix metalloproteinase
(MMP)13 expression in knee joint cartilage [52]. Howev-
er, since current evidence for PEMF as a disease-
modifying OA therapy is still weak, further studies are
needed to elucidate its molecular basis.
Mechanical Stimulation
In comparison to the rather limited evidence for effects of mag-
netic and electrical stimulation, a vast body of studies have
described the consequences of mechanical stimulation on artic-
ular cartilage or chondrocytes in tissue engineering strategies
[18•].We reviewmainly cellular responses of chondrocytes and
aspects closely related to osmotic stress, such as compression-
induced changes in HP and OP, as both are essential for stim-
ulating chondrocyte physiology and useful for manipulating
chondrocyte metabolism and phenotype [53].
Mechanical stimulation is an important regulator of chon-
drocyte metabolism that is required for maintaining normal
cartilage matrix properties [54, 55] and a well-established
cue for improving mechanical properties of tissue-
engineered cartilage [27], as reviewed by Vunjak-Novakovic
et al. [56] and Lee et al. [57]. A plethora of bioreactors have
been developed in which mechanical forces are applied via
compression, HP, shear, multimodal compression and shear,
vibration, bi-axial tension, and friction [18•]. While static
loading of tissue-engineered cartilage constructs, in general,
results in suppression of ECM biosynthesis, intermittent dy-
namic loading is usually beneficial and increases the biosyn-
thetic activity of chondrocytes. The cellular response to me-
chanical stimuli always depends on magnitude, frequency,
and duration of the stimulus, as well the relative timing of
the loading, the culture period, and the subpopulation of
chondrocytes. Importantly, the balanced activities of catabolic
and anabolic factors may be needed to stimulate native-like
ECM synthesis [58, 59].
IntrinsicMechanical Stimulation and Substrate Properties Cyclic
compression is required for chondrogenesis [60], while its
impact on the intrinsic material properties of cartilage is an
underappreciated aspect in tissue engineering. Using surface
topography, stiffness, or patterns to induce mesenchymal stem
cell (MSC) proliferation or differentiation [61] holds a lot of
potential for enhancing musculoskeletal regeneration [62•].
Our understanding of how cells sense the stiffness of ECM
or biomimetic substrates is rudimentary. Emerging mecha-
nisms of biophysically induced signals include focal adhe-
sions and cytoskeletal or Rho GTPase functions [63, 64]. Lo-
cal matrix stiffness can determine cell development, differen-
tiation, and regeneration through adhesion complexes [64]
with the actin–myosin cytoskeleton generating intrinsic con-
tractile forces by “sensing” substrate properties via pre-
stretching through actin stress fibers; linking integrin trans-
membrane receptors to ECM in mechanosensation enables
primary cells to alter their function in response to exogenous
forces [65] or oxygen tension and local cell density [66]. Ini-
tial attempts suggest the feasibility of creating 3D stiffness
gradients in hydrogels [67] to re-differentiate chondrocytes.
By manipulating substrate elasticity and adhesion density
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[68], stiffness may affect proliferation and RGD adhesion site
density during cellular differentiation. While the banding pe-
riodicity of collagen fibers in the ECM is 67 nm [69] and the
RGD epitopes of fibronectin fibers are ≥73 nm [70, 71], cells
are clearly sensitive to changes in interparticle spacing of
about 1 nm over a cell length [63],
That MSC fate can be re-directed, even after weeks, by
switching the biophysical microenvironment [72••] holds
promises for several cartilage-related tissue engineering appli-
cations. In contrast to generally unfavorable static compres-
sion, static pre-stretching of biomaterials may beneficially al-
ter (stem) cell behavior [73] through regulation of epigenetic
events [74]. Ameshwork of intermediate filaments and lamins
physically links chromatin to the cytoskeleton-mediated ex-
tracellular signal reception [75, 76]. Mechanical forces arising
frommatrix rigidity and nanotopography can physically affect
the structural organization of the nucleus [77], possibly direct-
ly altering gene expression and mechanical properties [63].
In combination with mechanical stimulation, incorporation
of chemical groups such as sulfates may improve chondrocyte
proliferation while inhibiting hypertrophic differentiation [78,
79]. By using intrinsic biomaterial cues to stimulate migration,
cell-seeded scaffolds appear promising for cartilage repair.
Similar to MSCs, chondrocytes respond to HP, fluid flow
(FF) and the accompanying shear stress, substrate strain and
stiffness or topography, and electromagnetic fields [80]. Fully
synthetic hydrogels can provide independent control over
physical and adhesive properties [81] for use in cartilage re-
generative medicine [82].
Osmotic Stimulation
Chondrocytes in cartilage represent cells under pressures of
different natures, like deformation, hydrostatic pressure, ex-
tracellular ion composition (i.e., OP), and streaming potential
(i.e., FF) [54]. Further, the concept is generally accepted that
matrix turnover by chondrocytes is influenced by changes to
the intracellular composition (e.g., cell volume, pH, and ionic
content). The pericellular microenvironment functions in situ
to mediate the chondrocyte (or chondron) responses to phys-
icochemical changes associated with joint loading [83]. Dur-
ing compression-induced changes in OP, the pericellular ma-
trix exerts important functions through amplifying cell vol-
ume changes [84]; such findings argue in favor of using
chondrons, rather than isolated chondrocytes, for osmo-
induced cartilage tissue engineering.
About 15 years ago [11], Mow et al. described the some-
times counter-intuitive effects of flow-induced compression of
the ECM and hypothesized that this friction-drag effect is
likely of major importance for fluid flow through the ECM.
Changes in HP and OP are essential for chondrocyte physiol-
ogy and useful for manipulating their metabolic function and
phenotype [53]. Applying controlled HP to cartilage or
chondrocytes can be technically challenging [53], while OP
is robustly defined as chemical. Unlike OP, tonicity is influ-
enced only by solutes that cannot cross the cell membrane.
Although chemical loading (i.e., OP) and mechanical loading
(i.e., HP) may not be exactly equivalent [85], the combination
of HP and OP produce gene expression profiles different from
those with OP alone, each stimulus by itself often results in
similar effects such as the stimulation of sulfated GAG syn-
thesis [53].
As OP is a state quantity, it changes during compressive
joint loading and off-loading; with zone-dependent concentra-
tions of sulfated GAGs causing OP gradients in articular car-
tilage [86]. In each zone, chondrocytes are subject to different
HPs and OPs due to weight bearing and joint loading [53, 32].
Applying HPs from 0 to 0.5 MPa at 0.5 Hz and OPs from 300
to 450mOsm can upregulate anabolic and catabolic molecules
in all three major zones in a descending order of magnitude
from the surface to the deep zone. Interestingly, HP off-
loading maintains anabolic messenger RNAs (mRNAs) and
reduces catabolic mRNAs, while high OP retains mainly cat-
abolic mRNAs [53]. Superficial zone-derived cells are most
sensitive to changes in HP or OP [53], which may explain
discrepancies between chondrocytes isolated from “normal”
and OA cartilage. The effects of OP on viscoelastic and
physical properties of chondrocytes are well described
[87]. Tonicity enhancer binding protein (TonEBP, also
known as nuclear factor of activated T cells (NFAT)5)
stimulates multiple cellular pathways for adaptation to
osmotic stress [88, 89] and organic osmolyte-dependent
and independent pathways [90]. Physiological and path-
ophysiological stimuli such as cytokines, growth factors,
receptor and integrin activation, contractile agonists,
ions, and reactive oxygen species have been implicated
in the positive regulation of TonEBP expression and
activity in diverse cell types [91].
Under standard FCS-containing expansion culture
conditions, proliferation of human chondrocytes seems
to be unhampered up to physiological osmolarity levels
(i.e., ∼350–400 mOsm) [92, 93]. Proteomic analysis of
serum-free expanded chondrocytes has confirmed a cut-
off threshold of about 350 mOsm, above which cell
cycle progression and proliferation appears compromised
[94, 95].
Molecular Aspects The response to osmotic loading seems to
depend on the nature of the osmotic stimulation and the chon-
drocyte phenotype, which is related to passage number and
pathological state [96]. Osmotic loading differentially regulates
SOX9 and COL2A1mRNA stability posttranscriptionally [97].
In nucleus pulposus cells, NFAT5 [98], together with intracel-
lular Ca2+ [99] and MEK/extracellular signal-regulated kinase
(ERK) signaling [100], control cell function, survival, and sul-
fated GAG synthesis [101, 102]. Hyperosmotic stress induces
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volume changes and Ca2+ transients in chondrocytes by trans-
membrane ion channels, phospholipids, and G-protein coupled
pathways [103].
Pritchard et al. [104] found that IL-1α alters the normal
volumetric and Ca2+ signaling response of porcine
chondrocytes to OP through mechanisms involving F-actin
remodeling and RhoGTPases. Human OA chondrocytes have
a more positive membrane potential (i.e., −26±4 mV) than
healthy cells and show reduced [Ca2+]o independent protein
kinase C (PKC)α-mediated hyperpolarization upon
hyperosmotic stimulation [105].
Osmotic loading is known to modulate chondrocyte
height, width, and volume in situ, and OP may modulate
cell shape in accordance with the primary collagen fibril
direction [106], as well as altering nuclear size and shape
[107]. Interestingly, osmotic sensitivity of nuclear shape
and volume appeared to be independent of the actin cyto-
skeleton. While compression (and thus increased OP) re-
duces the ECM, cellular, nuclear, rER, and mitochondrial
volumes, the Golgi apparatus seems relatively resistant to
intraorganelle water loss [108]. This may, at least partial-
ly, explain some of the observed posttranscriptional ef-
fects of OP [97].
Clinical Relevance Chondrocyte shrinkage by raised
hyperosmotic pressure (≥480 mOsm) may protect cells.
While most cell-based chondral repair strategies aim at
re-differentiation of routinely expanded, dedifferentiated
chondrocytes, van der Windt et al. showed that dedif-
ferentiation can be delayed by harvesting and expanding
cells under elevated (i.e., physiological, 380 mOsm) os-
molarity [92]. Interestingly, combining physiological os-
molarity with inhibition of calcineurin activity can in-
crease the expression of anabolic genes and suppress
catabolic genes, as well as hypertrophic markers, in hu-
man OA and “normal” chondrocytes [93] and may be a
promising strategy for improving cell-based chondral
defect repair. The clinical potential of applying osmolar-
ity to improve the chondrocyte phenotype is hard to
predict from present in vitro data, given the depth zone
dependence of osmotic responses [109] and the current
clinical practice of harvesting chondrocytes irrespective
of their original zonal location.
The effects of OP, to a certain extent, also depend on
the culture model: in alginate, higher proliferation rates,
with diminished sulfated GAG production, were found at
280 mOsm [110]. Of note, the pHi is also osmolarity-
dependent and its contribution to sulfated GAG produc-
tion remains speculative.
Finite element modeling showed that charged tissues (or
synthetic matrices) always support larger loads than un-
charged tissues. This load support derives from three sources:
intrinsic matrix stiffness, HP, and OP [111].
Regulation of Phosphatases by Chemo- and Biomechanics
Calcineurin as a Potential Target Molecule
A precisely set balance between the activities of protein
kinases and phosphoprotein phosphatases is crucial to
regulating chondrogenesis and maintaining the chondro-
cyte phenotype. All of the major protein kinase families,
including protein kinase A (PKA), PKC, mitogen-
activated protein kinase (MAPK), and CaMK, as well
as all major protein phosphatases (PP1, PP2A, and
PP2B) play fundamental roles in molecular regulation
in chondrocytes [112]. These signaling pathways even-
tually converge on targets that are involved in defining
the chondrocyte phenotype, and they regulate cell shape,
proliferation, differentiation, and gene expression (via
transcriptional regulators such as Sox9, cAMP response
element binding protein (CREB), and NFAT; see details
below).
The Ca2+-dependent serine/threonine phosphoprotein
phosphatase calcineurin (Cn; also known as PP2B) has been
identified as a potential target to improve the chondrocyte
phenotype. The Cn inhibitor FK506 (also known as Tacroli-
mus) increases the expression of chondrogenicmarkers during
in vitro expansion in hypoosmotic culture medium [113]. Iso-
lation and expansion of adult human articular chondrocytes in
culture medium of physiologic osmolarity (i.e., 380 mOsm)
improves chondrogenic marker gene expression and ECM
production through NFAT5 [92]. Interestingly, FK506 within
the range of 0.1 and 1000 ng/mL increased not only COL2A1
but also COL10A1 expression, while in human OA cells
FK506 suppressed the osmolarity-induced COL10A1 expres-
sion [93]. Generally, similar anabolic and anti-hypertrophic
effects were observed in ex vivo cartilage explant cultures
and non-OA chondrocytes. Similar data were reported with
alternative Cn inhibitors (i.e., cyclosporine A, CsA) in human
cells [114] and in the murine AT805-derived chondrogenic
ATDC5 cell line [115], where FK506 increased PG content
in a dose-dependent manner without elevating alkaline phos-
phatase (ALP) activity.
The exact mechanism underlying the effects of Cn inhibi-
tion under different osmolarities is not yet understood, but Cn
is known to induce FGF18, which can suppress noggin and
facilitate BMP-related chondrogenesis-like effects [116]. This
pathwaymay involve, among others, NFAT4-mediated induc-
tion of BMP2 [117]. FK506, but not CsA, induces ATDC5
differentiation [118], suggesting that FK506 promotes
chondrogenic differentiation, at least partly, by Cn-
independent signaling routes. Since FK506 has been proven
effective and safe as an anti-rheumatoid arthritis drug [119,
120], this approach may improve cell-based chondral repair
strategies by interfering with adverse inflammatory or im-
mune cell-mediated effects.
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Cn–NFAT Signaling in Cartilage Pathologies
Cn regulates the activity of NFAT family members in a spe-
cific and Ca2+/calmodulin-dependent manner [121]. For a de-
tailed overview of this vertebrate-specific phosphatase in
chondrocyte physiology, the reader is referred elsewhere
[112]. NFATs have arisen from an ancient precursor with a
Rel domain, and Cn–NFATsignaling may be an essential pro-
cess during vertebrate development [122].
After the original study by Glimcher’s group had shown
that all four NFATc1–4 proteins are expressed in the cartilage
[123], Greenblatt and colleagues recently expanded the earlier
studies of Ranger et al. and Wang et al. [123, 124] by demon-
strating essential functions of NFATs (i.e., NFATc1 and
NFATc2) in articular cartilage homeostasis [125]. NFATs have
the potential to link many extracellular signals to the nuclear
transcriptional machinery [126].
Greenblatt’s cartilage-specific NFATc1 and NFATc2 dou-
ble mutant mice showed accelerated cartilage degeneration
and expression of OA markers, such as increased expression
of genes encoding proteases involved in ECM degradation
such as MMP13, ADAMTS-5, and hypertrophic chondrocyte
markers, including COL10A1, and reduced expression of
Sox9 and PRG4, encoding lubricin. Intriguingly, NFATc1 pro-
tein expression is restricted to the superficial zone of articular
cartilage, and its mRNA expression is reduced around carti-
lage lesions in human osteoarthritic patients [125]. A number
of earlier in vitro studies suggest that NFATsignalingmay also
induce catabolic genes such as ADAMTS4 and 9 in
chondrogenic cells [127, 128], which are findings contradic-
tory to the protective roles observed in vivo. While NFATc3
seems less important for cartilage homeostasis, it may still be
relevant in chondrogenesis [117].Most notably, multiple path-
ways co-regulate the subcellular localization of the four Ca2+-
dependent NFAT proteins (NFATc1–4). In contrast, osmotic
stress, rather than Ca2+ signaling primarily regulates the more
distantly related fifth family member NFAT5, as discussed
above.
A recent study showed that lentiviral shRNA-mediated
Nfatc2 knockdown in articular chondrocytes in vitro largely
matches the in vivo phenotype and also upregulates pro-
inflammatory cytokines [129]. In tracheal cartilage, CaV3.2
T-type Ca2+ channels may be involved in Cn–NFAT-depen-
dent modulation of Sox9 expression [130••]. A previous study
using other Cn inhibitors such as CsA had already suggested
the participation of Ca2+ channels [131].
Pharmacological inhibition of Cn by FK506 promotes
chondrogenic marker expression in dedifferentiated human
adult chondrocytes, probably through upregulation of TGFβ1
[113]. NFAT activity seems tightly regulated by upstream sig-
naling pathways: both activators (Cn) and inhibitors (e.g.,
GSK-3) can link a large number of mechanical and biochem-
ical stimuli to this protein family, but few extracellular
regulators of NFAT activity in chondrocytes have been iden-
tified to date. Not surprisingly, pharmacological inhibition of
GSK-3β signaling increases cartilage degeneration in rats
[132], while FK506 in the same species protects the collage-
nous ECM of articular cartilage against osteoarthritic wear-
and-tear erosion [133]. At present, it is not clear whether these
effects are due to altered NFAT activity or other pathways
affected by the inhibitors of Cn (CsA or FK506) or GSK
(GIN). Earlier studies suggest a link between osmolarity-
induced signaling pathways such as MAPK or Ca2+ signaling
and Cn–NFAT signaling, which may be integrated through
NFAT5. NFAT activity and expression in chondrocytes
in vitro seems also to be dependent on both Notch and Wnt5a
signaling, at least in growth plate chondrocytes [134, 135],
and its relevance for articular chondrocytes, especially
in vivo, remains to be shown.
Overall, in vivo and in vitro data from mice and humans
strongly suggest a dynamic control of NFATc2 expression in
articular cartilage and a crucial role of NFAT family members
in cartilage homeostasis and joint health. NFATs might be
involved in distinguishing articular from growth plate
chondrocytes, the origins of which are still not understood
completely [136]. Novel small molecular compounds with
higher specificities may make NFATs potential therapeutic
targets for cartilage regenerative medicine and anti-
osteoarthritic treatment regimes.
The Role of PKA and PP2A in Mechanical Stimulation
and the Chondrocyte Phenotype
Amain function of articular cartilage is to absorb shock during
joint movements. Chondrocytes are sensitive to mechanical
load, one of the most physiological stimuli that trigger the
activation of key signaling molecules. Although appropriate
mechanical stimuli are essential for limb development [137],
differentiation of MSCs [138], and cartilage regeneration dur-
ing OA [139], mechanotransduction pathways in differentiat-
ing or mature chondrocytes are still incompletely understood
[140•].
Although mechanosensitive ion channels, primary cil-
ia, and the actin cytoskeleton have all been implicated
as mechanosensors in chondrocytes, downstream path-
ways are even less well characterized. Of the major
signaling pathways, integrins and focal adhesion kinases
(FAKs), the ERK, and the PI 3-kinase/Akt pathways
have been reported [141]. It is of note that activation
of the cAMP–PKA–CREB axis following mechanical
stimuli has been documented in different models [142].
PP2A also plays a regulatory role in p38 MAPK acti-
vation during cyclic strain [143]. Oscillating mechanical
load promotes chondrogenesis and stimulates cartilage
ECM product ion in chicken l imb bud-der ived
micromass cultures, and the observed effects can be
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attributed to the activation of PKA/CREB–Sox9 signal-
ing and concurrent inhibition of the PP2A pathway
[144]. Here, we propose that increased PKA activity
results in enhanced Sox9 and CREB phosphorylation
and nuclear translocation; these in turn facilitate
chondrogenic differentiation and ECM matrix produc-
tion. Given that PP2A is a negative regulator of chon-
drogenesis and balances the effects of PKA by dephos-
phorylating many common targets, its reduced activity
further enhances the chondrogenesis-promoting effects
of mechanical stimulation in this model. Interestingly,
previous data also indicated a direct interplay between
PKA and PP2A during chondrogenesis [145] and
strongly support the important role of reversible protein
phosphorylation in establishing and maintaining the
chondrocyte phenotype.
Serially passaged articular chondrocytes, deprived of their
ECM, rapidly lose their characteristic phenotype. Signaling
events that control the re-differentiation of dedifferentiated
chondrocytes have only partially been analyzed. Chondrocyte
re-differentiation in micromass cultures may be mediated by
PKC-dependent ERK1/2 regulation, whereas chondrocyte de-
differentiation is under a separate control by PKCα and
ERK1/2 [146]. In a different study, p38 MAPK along with
PKCα activity was reported to be essential for chondrocyte
re-differentiation [147]. Since cyclic hydrostatic pressure
upregulates cartilage-specific gene expression during re-
differentiation of dedifferentiated bovine articular
chondrocytes [148], one can speculate that mechanical load-
induced activation of protein kinases and/or phosphatases
may be responsible, at least partially, for these effects.
Calcium Signaling Is an Essential Component
in Mechanotransduction Pathways in Differentiating
and Mature Chondrocytes
Intracellular Ca2+ signaling and changes in cytosolic Ca2+
concentration are closely related to cell proliferation and dif-
ferentiation in chondroprogenitor cells, and Ca2+ release from
intracellular stores and influx through plasma membrane ion
channels are key factors controlling chondrogenesis [149].
Various chondrocyte plasma membrane ion channels appear
to be regulated by mechanical stimuli, such as the big con-
ductance Ca2+-activated K+ channel (BK-like channel) [150]
or the transient receptor potential vanilloid 4 (TRPV4) cation
channel [151••]. Mechanical load-induced Ca2+ influx and
subsequent alterations in Ca2+ signaling have been document-
ed in chondrocytes upon both compressive loading and HP
[152]. Furthermore, cyclic compression is known to modulate
cartilage matrix synthesis and catabolism through an
autocrine/paracrine purinergic pathway; compression-
induced ATP release evokes Ca2+ transients via activation
of P2X and P2Y receptors that cause a combination of extra-
cellular Ca2+ influx and intracellular Ca2+ release in agarose-
embedded chondrocytes [101]. How exactly Ca2+ signaling is
coupled to mechanosensation in chondrocytes remains an
open question.
Fig. 1 The effects of electrical,
magnetic, and mechanical
stimulation on articular cartilage
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A promising candidate for a mechanosensory organelle on
chondrocytes is the primary (non-motile) cilium, first identi-
fied on articular chondrocytes almost 40 years ago [153]. Tis-
sue compression during joint loading can lead to deformation
of the cilium, which in turn may trigger signaling involved in
mechanotransduction pathways. Indeed, various extracellular
matrix receptors including integrins, as well as osmo- and
mechanosensitive ion channels including TRPV4, are known
to be present on its surface [140•]. In particular, the primary
cilium is necessary for compression-induced ATP release and
Ca2+ signaling via P2X and P2Y purinergic receptors, induc-
ing aggrecan mRNA expression and sulfated GAG secretion
in a 3D chondrocyte culture system [154]. These findings
suggest that the primary cilium does not act as the initial
mechanosensor in that model, leaving several open questions
regarding its specific role in chondrocyte mechanosensation.
Conclusions
The effects of electrical, magnetic, and mechanical stimu-
lation on articular cartilage are summarized in Fig. 1. Data
are accumulating regarding the molecular identity of the
sensors and the mechanotransduction signaling apparatus
in chondrocytes that convert the effects of external forces
to cellular responses. Diverse stimuli have been shown to
exert chondroprotective effects, but our current knowledge
is still incomplete and a better understanding of the molec-
ular identity and function of mechanotransduction path-
ways is of crucial importance. It is very important to em-
phasize that the mechanical properties of native cartilage,
and thus the responsiveness of chondrocytes to external
stimuli, vary widely and depend on joint location, depth
in the tissue, sample orientation, species, and donor age.
These differences have important implications for cell-
based regenerative approaches and should be considered
during data interpretation. Further research should aim at
understanding which load-induced biophysical changes are
most important for cartilage ECM regeneration and main-
tenance of the chondrocyte phenotype to benefit functional
cartilage tissue engineering.
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